⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30748792 | 0.82 | BRD4 (0.37) | — | |
| SCHEMBL30748990 | 0.69 | MEN1 (0.31) | — | |
| SCHEMBL30748904 | 0.67 | RAD51 (0.42) | — | |
| SCHEMBL30749007 | 0.67 | ELANE (0.44) | — | |
| SCHEMBL30748931 | 0.66 | PDE3B (0.41) | — | |
| SCHEMBL30749136 | 0.65 | ACACB (0.37) | — | |
| SCHEMBL30749146 | 0.64 | ADRA1A (0.35) | — | |
| SCHEMBL30748903 | 0.63 | ALOX15 (0.35) | — | |
| SCHEMBL30748983 | 0.62 | PGR (0.37) | — | |
| SCHEMBL30748768 | 0.59 | IRAK4 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304571-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) | 2025-10-02 | — | — | US | disclosed |
| EP-4565588-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | Suzhou Keen Therapeutics Co., Ltd. (CN) | 2025-06-11 | — | — | EP | disclosed |
| WO-2023241620-A1 | BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF | SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) | 2023-12-21 | — | — | WO | disclosed |